According to the good genes hypothesis and energy allocation theory, human adult body height may reflect biological quality. An important aspect of this quality is immune system functioning (ISF). The aim of this study was to evaluate the relationship between ISF and body height in healthy people. The ISF was determined by several important innate (total complement and lysozyme activity, neutrophil function) and adaptive immune parameters (lymphocytes, IgA and IgG, and response to the flu vaccine). Overall, 96 males and 97 females were subjected to flu vaccination, and of these, 35 males and 34 females were subjected to tetanus. Blood samples were collected before and four weeks after vaccination. Immunomodulatory factors, participant's age, body fat, and free testosterone levels, were controlled. There was no association between body height and all analysed immune parameters for both sexes. That might suggest that in Western society, a women's preference for taller men is not related to 'good genes for immune competence'. We propose the novel Immunity Priority Hypothesis that explains the lack of relationship between adult body stature and ISF. This hypothesis, however, does not contradict the signalling role of a man's body height as a morphological marker of biological quality.
Background
Body height is the most conspicuous morphological human trait and has important ecological and social consequences. Height perception, however, both in mating and non-mating contexts, has more important consequences for men than for women (see review by Stulp & Barrett [1] ). According to the good genes hypothesis, female choice is based on male fitness-related traits that might signal viability benefits for offspring. Studies show that in most societies, women prefer taller men (but see Sorokowski et al. [2] for the lack of such preference) and it is the most important morphological trait of handsomeness or a man's physical attractiveness [3] [4] [5] [6] [7] . Taller men have a greater chance to marry earlier in their life [8] and have more partners, both in monogamous [9] and in polygynous societies [10] or remarry more often [11] . They also have a lower risk of being childless [12] , passing their genes to the next generation. Previous studies have hypothesized why taller men are preferred by women [1, 13] . Apart from the potential advantage of male stature in intrasexual competition, or increased chance to achieve higher socioeconomic status (SES), taller men might have better physiological quality. This might be related to the pleiotropic effects of the genes responsible for height and/or for higher immune quality. The latter might enhance immunity to pathogens or assure sufficient energy for growth even if affected by different factors that disturb growth during childhood [14, 15] . Studies on discordant body height in monozygotic twins (MZ) indicate that infection frequency during early childhood affected growth and was responsible for height difference between the twins [16] . Height might inform about past episodes of illness or physiological stress and therefore about immune competence in general. Other reports & 2017 The Author(s) Published by the Royal Society. All rights reserved.
showed that MZ twins discordant for height were also discordant for mortality [17, 18] .
Although male height has high heritability in Western countries (0.87 -0.93 [19] ), it is influenced by many environmental factors, such as nutrition, stress, or parasite contagion [20, 21] . However, from the mating perspective, it might be negligible if an organism is genetically determined to be short or could not accomplish his genetic potential for height because of frequent disease in childhood. In both cases, height might be a signal of biological advantage or potential fitness.
If male height is a signal of biological quality, then it would be expected that in a given population, relatively taller men are healthier or live longer [14, 15] . Although taller people are more prone to develop cancer, when all death causes were included in analysis, height was inversely related with risk of death [22, 23] . In other studies [24, 25] , SES did not eliminate the height effect on the morbidity and mortality risk related to coronary heart diseases (CHD). However, height and CHD were negatively correlated for men but not for women [23] . It is unclear whether there are any genes that influence body height and immune functions ( pleiotropy). A genome-wide association study (GWAS) indicated an interplay between height and the immune system [26] justifying further studies on the relationship between height and immune effectiveness.
Studies on Latvian samples conducted by Krams et al. [27] and Skrinda et al. [28] indicated a positive correlation between male, but not female, height and immune response to hepatitis B vaccination. The authors claimed that male body height is a signal of immune efficacy as body size is an expensive trait to produce and maintain; thus, it supports the immunocompetence handicap hypothesis [29] . These studies of humans showing a relationship between height and immune response only used one antigen. Here, we investigated whether body height is correlated with immunological quality by examining adaptive and innate immune parameters. We measured lymphocyte counts and immunoglobulin levels, and also determined the efficiency of influenza and tetanus vaccinations. The assessment of innate status involved the measurement of total complement and lysozyme activity as well as neutrophil function including phagocytosis and reactive oxygen species (ROS) production. Because immune parameters are strictly related to health status, in addition to self-declaration and medical examination, we also evaluated basic markers of inflammation and parameters reflecting abnormalities in liver/kidney/pancreas function.
Our main hypothesis was that body height indicates immune system quality, which is positively related to some adaptive or innate immune parameters. Furthermore, if male attractiveness and physiological quality is attributed to body stature, then height should be strongly related to immune efficacy in men compared with women.
Material and methods (a) Participants
The study group were selected from Polish volunteers recruited by local newspapers, social media, and radio. Most subjects declared they came from a big or small city (over 72%), and lived in Wroclaw or its suburbs. The majority of participants had a university degree (62%), or had completed high school and were now students (36%). According to self-declaration about their socioeconomic condition, the study group was homogeneous with a high or average SES (97%), whereas only a few declared a low SES. The place of living and SES were unrelated to height and immune factors, so were not controlled in further analyses.
Overall, 134 men aged 18.9 -36.7 years and 126 women aged 18.6-36.1 years, declaring no chronic diseases (diabetes, autoimmune disorders, metabolic or hormonal problems) and no symptoms of infection were recruited. Participant general health status was also examined during medical qualification for vaccination by biochemical tests of subject blood.
Blood cell morphology with smear (total leucocyte count, leucocyte subpopulation) and biochemical tests (C-reactive protein, transaminase (Alt, Ast), creatinine, fasting glucose levels) were performed for all participants. Factors that might strongly affect immune parameters, such as adiposity, androgens, and cortisol levels, were also measured. Participants who had biochemical blood parameters above the normal range (seven men and three women), body mass index (BMI) At the same visits, 35 men and 34 women also received a tetanus toxoid vaccine (Tetana, Biomed w ) in addition to the flu vaccination, to evaluate immune responses to an evolutionarily conservative antigen. Before vaccine injection, the participants' blood was collected for immunological, hormonal, and biochemical analyses. A second blood collection was done approximately four weeks after vaccination (24 -32 days, mean 28 days) to assess an individual's ability for specific anti-flu or anti-tetanus antibody production.
Tests conducted on whole blood samples (neutrophil functions and immunophenotyping) were started within 2 h from collection. Serum was separated, portioned, and frozen (2708C) until further analyses.
(c) Assessment of immunological parameters (i) Innate immune parameters
Total complement activity. The activation of all three complement pathways was assayed in zymosan-activated serum using commercial EIA kits (MicroVue, Immunogen w ) according to the manufacturer's instructions. Test procedures of serum activation were described previously [30] . Absorbance was measured using a spectrophotometer (Asys340, Biochromw). Results were calculated in relation to a standard curve and expressed in ng ml 21 . rspb.royalsocietypublishing.org Proc. R. Soc. B 284: 20171372
Lysozyme activity. Lysozyme activity of human serum was measured by lysis assay using a Micrococcus lysodeikticus (Sigma Aldrich w ) cell suspension. A decrease in the turbidity of the test sample containing bacteria with serum and a control sample consisting of bacteria with buffer was measured after 20 min incubation using l ¼ 450 nm and a spectrophotometer (Asys340, Biochromw) [31] . The results were calculated as the difference in absorbance value between the control and test sample. A greater difference reflected higher lysozyme activity in a participant's serum.
Neutrophil phagocytic activity. Phagocytic activity of peripheral blood neutrophils (PMNs) was assayed using functional responses, phagocytic uptake, and the generation of ROS. Phagocytic uptake was performed using commercial kits containing Escherichia coli strains (PHAGOTEST, Glycotope w ) according to the manufacturer's instructions. Measurements were taken by flow cytometry using a FACSCalibur flow cytometer (Becton Dickinson w ). To quantify microbial uptake, WinMDI 2.9 software was used. The results were expressed as the mean fluorescent intensity of phagocytosing neutrophils.
ROS production, defined as oxidative burst by isolated PMNs, was measured using a luminol-dependent chemiluminescence assay (CL) in white flat-bottom microplates, as described previously with slight modifications [32] . Briefly, PMNs were stimulated with PMA (Phorbol 12-myristate 13-acetate) in the presence of luminol as a luminescent probe. CL kinetics was measured using a luminometer for 45 min and recorded as relative light units (RLU). The area under the chemiluminescence curve (AUC CL ) for PMA-stimulated neutrophil chemiluminescence (AUC-PMA) and for baseline luminol chemiluminescence (AUC-control) were calculated. Relative CL was calculated as the mean AUC CL -PMA divided by AUC CL -control. Results were expressed as the mean + s.d.
(ii) Adaptive immune parameters
Absolute count of T and B lymphocytes
Quantitative assessment of the key population of peripheral blood lymphocytes (T cells and B cells) was performed using fluorochrome-labelled monoclonal antibodies and measured by flow cytometry. Commercial kits from Becton Dickinson w were used to identify and determine the absolute counts of mature human B lymphocytes (CD19): TriTest CD3 FITC/CD19 PE/CD4 PerCP and T lymphocytes (CD3): TriTest CD4 FITC/CD8 PE/ CD3 PerCP. The specimen collection and test procedure were performed according to the manufacturer's instructions. The results were calculated using BD CellQuest software and expressed as the number of positive cells (CD3 or CD19) per microlitre of blood (cells ml
21
).
Total IgA and IgG levels
Serum immunoglobulin concentrations were measured with enzyme-linked immunosorbent assay (ELISA), using previously calibrated reagent concentrations and a dilution series of the participant's serum [33] . Absorbance was measured using l ¼ 490 nm on a spectrophotometer (Asys340, Biochromw). Results were calculated in relation to the standard curve and expressed in g l
21
.
Anti-flu antibody titre detection
To evaluate the strength of the immune response to the flu vaccine, the titre of a specific IgG antibody was measured before and four weeks after vaccination according to immunological standards [34] . The anti-flu antibody titre was measured with the standard ELISA method. Briefly, microplates (Maxisorp NUNC w ) were coated with influenza vaccine antigens (Vaxigrip w , SanofiPasteur). After a series of incubations, the absorbance was measured using l ¼ 490 nm. The antibody titre was defined as the reciprocal value of the highest dilution of the serum sample giving a positive test reaction below OD ¼ 1. Because all participants had some level of specific anti-flu antibody in their blood sample before the flu vaccination, the strength of the immune response to the vaccine was expressed as fold-increase between pre-and post-vaccinationspecific antibody titre. The immune response to the flu vaccine was analysed as both a continuous variable and categorized variable. In the latter group, those characterized by a positive response (seroconversion) were compared to the group with a lack of response to vaccination (lack of seroconversion).
Anti-tetanus antibody titre detection
The evaluation of a specific anti-tetanus antibody was performed before and four weeks after vaccination, using a commercial kit (DEMEDITEC w ). Serum sample dilution and test procedures were conducted according to the manufacturer's instructions. The results were calculated in relation to a standard curve and expressed in IU ml 21 . All participants had a detectable level of specific anti-tetanus toxoid antibody in their blood sample before vaccination. The strength of the immune response to the tetanus vaccine was expressed as the fold-increase between pre-and post-vaccination-specific antibody concentration. Because of the small sample size, the immune response to the tetanus vaccine was analysed only as a continuous variable.
(d) Hormone measurements
Free testosterone (fT) and cortisol concentrations were measured in each subject's serum. Hormonal analyses were evaluated by ELISA using appropriate commercial kits (DEMEDITEC w ). Serum samples were assayed in duplicate according to the manufacturer's instructions. Hormonal concentrations were calculated in relation to a standard curve and expressed in pg ml 21 for fT and in ng ml 21 for cortisol.
(e) Body measurements
Body height and weight were measured during the first visit twice and the mean value was calculated. BMI was calculated as weight (kg) divided by height (m 2 ). BFP was measured using a bioimpedance analyser (Bodycomp MF, AKERN, Italy) and calculated using the manufacturer's software (BodyGram 1.2, Akern Bioresearch, Italy).
(f ) Immunomodulatory factors controlled in regression analyses
Because immune mechanisms might be influenced by a participant's age [35, 36] , the amount of fat tissue [37, 38] , and androgen levels [39, 40] , we controlled all these factors in the first-step linear regression model. Because we observed significant differences in a few immune parameters between the groups recruited over two flu seasons (2013/2014 and 2014/ 2015), the season of the study was also controlled.
(g) Statistical analysis
The descriptive statistics are presented using raw data, but in the regression analyses, we used data following natural logarithmic transformation to normalize the residuals distribution. Analyses were carried out using Statistica 12 (StatSoft Incorporated).
Results
The descriptive statistics for all studied traits such as participants' age, and immunological, hormonal, and morphological measurements are presented in (a) Immune system parameters and body height
The simple relationship between male body height and selected innate (figure 1a -c) and adaptive (figure 1d-f ) immune factors are presented in figure 1 . For each sex, we separately tested the relationship between immune parameters and potential factors that might affect the analysed immune functions such as participant's age, fT level, BMI, BF, and the study season. Because vaccine interference was reported in the literature [41] , tetanus vaccine injection ('yes' versus 'no') was also controlled when the immune response to the flu vaccine was analysed. A series of linear regressions for each immune parameter were conducted.
Male age appeared to be a significant predictor for CD3 For women, only age was a significant predictor for the strength of tetanus post-vaccination response (b ¼ 0.49, t ¼ 3.14, p , 0.01). The study season was a significant predictor for the majority of innate and adaptive immune parameters in both sexes and was controlled in the multiple regression model.
In the second step, controlling for factors that predicted immune parameters in linear regressions, we tested the relationship between immune parameters and body height (separately for each sex). To test the relationship between immune factors and female body height, a regression model was constructed with the same procedure as for males. There was no single immune parameter that was predicted by male (table 2) or female (not presented here) body height.
Because of strong immunomodulatory properties of age, adipose tissue, and free testosterone, we also performed the same analyses for all these predictors included in every multiple regression model as previously reported (table 2) . It is possible that their combined influence on immune parameters might be stronger than when analysed separately. The regression analyses with multiple immunomodulatory predictors (data not shown) did not change the previous results.
To check whether combined innate parameters might be related to body height compared with when analysed separately, we constructed a regression model with body height as a dependent variable and all innate parameters as (table 3a) . The same procedure was used to check the relationship between the body height and all adaptive parameters (table 3b) .
The strength of the immune response to flu vaccination was also tested in accordance with immunological standards as a positive (seroconversion) or negative (lack of seroconversion) response [34, 42] . Seroconversion after flu vaccination, reflected by at least a fourfold increase in the antibody titre, was present in 71 men and 67 women. These participants did not differ significantly in body height from the non-seroconverted group (two-sample t-test: males:
Discussion
According to the good genes hypothesis, human body height should be a signal of general biological condition. Body height might relate directly to genes that also influence immunity as indicated by a GWAS, or to a development effect related to life history and factors that disturb growth such as infectious disease frequency in childhood. The latter case might also be related to an individual's immune efficacy-a more efficient immune system and less frequent and less severe infection episodes. Because the immune system is one of the most important body functions for survival, it is an important determinant of fitness.
Here, we tested whether male and female body height was related to adaptive or innate immunity. Our results indicate that in the studied population, there was no relationship between body height and adaptive immune response (measured by the absolute number of T and B lymphocytes in peripheral blood, total IgA and IgG serum levels, and the strength of the immune response to the flu or tetanus vaccine) and innate immunity (measured by total complement activity, lysozyme activity and neutrophil function). It is worth noting that we studied the response to flu vaccination both as a continuous variable and categorized in groups with a positive versus negative immune response.
Our result is in agreement with the result for women obtained by Krams et al. [27] , who only studied the immune response to the hepatitis B vaccine (HBV). However, our result does not confirm the positive relationship between height and strength of immune response for men obtained by Krams et al. [27] and Skirinda et al. [28] . There are a few rspb.royalsocietypublishing.org Proc. R. Soc. B 284: 20171372 important differences between these studies. First, to test adaptive immunity, we used different antigens and also tested the fold increase from pre-to post-vaccination antibody levels. Second, because immune parameters are modulated by various factors, the exclusion criteria in our study were very strict. We excluded all subjects declaring ongoing infection, and those with biochemical blood parameters indicating ongoing inflammation processes (CRP . 5.0 mg l 21 , leucocyte levels . 10 000 ml
21
), liver dysfunction (both ALT and AST 41 U l 21 ), or abnormal sex hormones levels. We also excluded obese individuals (BMI . 30). Krams et al. [27] and Skrinda et al. [28] did not control for the basic medical indicators of general health status, or for common immunomodulatory factors affecting antibody production (e.g. adiposity). It is well known that adipose-derived immune imbalance or diseases cause local or systemic immunosuppression [43] . Previous well-documented studies reported that an excess of body fat negatively impacted the immune response to the HBV vaccine [44] [45] [46] . Third, our male subjects were older with a broader age gap (mean age was 27 years, age range: 19-37 years). Our results are consistent with other studies [44, 47] , but not with Krams et al. [27] , and Skrinda et al. [28] regarding the negative relationship between vaccine-induced immune response and age of men. Last, it is unclear whether the two studies conducted on Latvians are representative and independent of each other; it is likely that the sample studied by Skrinda et al. is a subsample of the subjects studied by Krams et al. There are many studies on the relationship between BMI (calculated on the basis of height and body mass) and immune response to the A or B hepatitis vaccine [44 -46,48,49] ; however, none of these studies found a relationship between height and immune response, suggesting the results of the Latvian sample(s) are an exception. In our opinion, the difference between our results and those obtained by Krams et al. [27] cannot be explained by the fact that the subjects from Krams et al. study had grown up in an undeveloped eastern part of Latvia, therefore had lived their childhood and youth in relatively harsh environmental conditions. The mean body height of their male subjects was 180.5 cm (and for females 167.8 cm), which is close to the national mean. Moreover, it is well known that adult body height is a good biological measure of early life environment ( [50, 51] see also in [52] ). The fact that officially (it is hard to assess any unofficial sources) they had a relatively low income per family member, it does not mean that they suffered any food deficiency. Furthermore, we assume that the economic situation of Polish and Latvian families were similar in the late 1980s and early 1990s. At that time, both countries went through an economic transition and gained either formal (Latvia) or not formal (Poland) independence from the Soviet Union. We doubt that our participants were less affected by their early life environments than Latvians were and that the differences in the results for males between our studies can be explained by early life environments.
To our knowledge, this is the first investigation of the relationship between body height and the adaptive immune response against a fast-evolving flu virus antigen and against a conservative bacterial antigen (tetanus toxin). It is also the first report on the relationship between innate immunity and a morphological trait included in the attractiveness criteria. Total complement activity, lysozyme activity, and neutrophil functions ( phagocytic uptake and ROS production) were not related to male or female height. However, the statistical power for the relationship between adaptive immunity parameters was high (except for IgA), and the power for innate parameters was only moderate and therefore, we should treat these results cautiously.
In the context of the immunocompetence and energy allocation hypothesis, there were a few limitations in our study. The first is related to the SES studied population, which is relatively well nourished, living with high sanitation levels and good medical care. In such an environment, an organism can easily secure energy for all body functions and growth at the same time. Furthermore, adult height in such societies is mainly determined by genetic factors, confirmed by the very high heritability of height in Western populations [19] , with only minor influence of the variation in environment. Therefore, it is likely that the abovementioned hypotheses may be correct mainly in poorer non-Western societies, living in an environment with a high pathogen burden.
We cannot completely discard the idea that height indicates immune quality because we did not study all immunity components (natural killer cells, macrophages, monocytes, dendritic cells, or regulatory T-cell function were not studied). It is also worth noting that we measured antibody responses for particular pathogens (antigens) after booster immunization, whereas the strength of the immune response to the vaccine might also be antigen dependent and different for the first and second exposure to the antigen. Furthermore, the energetic cost for vaccine-induced immune activation might be lower than for an immune response induced by a natural infection. The difference between immune activation induced by vaccine or natural infection is mainly related to careful control of the safety and immunogenicity of a vaccine and the absence of microbial replication in non-live vaccines [53] . We also did not control for other traits including adverse economic and social conditions in childhood (e.g. psychosocial stress or housing conditions) that are known to influence stature in adulthood [54, 55] . Our participants were unlikely to have suffered any reduction in nutritional status during childhood, thus this factor should not affect the obtained results.
With all the caveats in place, we propose a new 'Immunity Priority Hypothesis' (IPH) that might explain the lack of a relationship between body height and immune efficacy and at the same time maintain the validity of body stature indicating biological quality. Our hypothesis, based on the trade-off concept related to the principle of energy allocation reported by Stearns [56] , suggests that unless an organism spends enough energy for immunity, it cannot invest in growth.
Because optimal immunity is very expensive to develop and maintain, it might limit other body functions and traits including growth. This suggests that an organism's priority is to secure the best possible immune quality. Considering the genetic and nutritional factors of growth, realizing the genetic potential for height would then be 'second' in priority. In this case, it should be expected that taller men or women would have a stronger immune system than shorter individuals, as they were able to secure more additional energy for growth. IPH also suggests that contrary to many functions, an organism cannot trade on immunity; they cannot divert investment away from costly immunity, particularly during infections. To confirm our hypothesis, further studies, preferably on populations living in more ecologically diverse environments, are recommended.
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